BDBM50105979 1-(4-tert-Butyl-phenyl)-4-[(2-hydroxy-4-sulfo-naphthalen-1-yl)-hydrazono]-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid ethyl ester::CHEMBL338532

SMILES CCOC(=O)c1[nH]n(-c2ccc(C(C)(C)C)cc2)c(=O)c1N=Nc1c(O)cc(S(=O)(=O)O)c2ccccc12

InChI Key InChIKey=UDMVBWHZJXETRF-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50105979   

TargetThrombopoietin receptor(Human)
Glaxosmithkline

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50105979BDBM50105979(1-(4-tert-Butyl-phenyl)-4-[(2-hydroxy-4-sulfo-naph...)
Affinity DataEC50:  2.00E+3nMAssay Description:Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed